TEI enters surgical mesh sector with TissueMend
This article was originally published in Clinica
Executive Summary
Development-stage biomedical firm TEI Biosciences is gearing up to launch its first products in the US, after gaining FDA clearance for its surgical mesh for reinforcing or repairing soft tissues.